{"transactions":[{"id":3345394,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":4,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":6,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T10:47:42.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":340134,"price":2.92,"value":993191.28,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Puissance Cross-Border Opportunities IV LLC made an in-kind distribution of 176,992 shares of common stock. Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 163,142 shares of common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Consists of: 76,048 Shares directly owned by Puissance Cross-Border Opportunities V LLC."}],"balance_after":76048,"source":{"system":"sec-edgar","filing":"0001733439-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1733439/000173343919000001/primary_doc.xml","form_type":"4"}},{"id":3345393,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":4,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":6,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T10:47:42.000Z","date":"2019-12-05","kind":"sale","acquired":false,"shares":43996,"price":3.05,"value":134187.8,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 43,996 shares of common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Consists of: 239,190 Shares directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Shares directly owned Puissance Cross-Border Opportunities IV LLC."}],"balance_after":416182,"source":{"system":"sec-edgar","filing":"0001733439-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733439/000173343919000001/primary_doc.xml","form_type":"4"}},{"id":3745921,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745920,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745919,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"sale","acquired":true,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}},{"id":3745918,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}}]}